![Merck & Co diversifies its oncology portfolio further by acquiring VelosBio for $2.75bn - Pharmaceutical Technology Merck & Co diversifies its oncology portfolio further by acquiring VelosBio for $2.75bn - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2020/11/shutterstock_1642618876-1.jpg)
Merck & Co diversifies its oncology portfolio further by acquiring VelosBio for $2.75bn - Pharmaceutical Technology
![Sep 21, 2020 South San Francisco / CA / USA - Merck & Co. logo at their headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational Stock Photo - Alamy Sep 21, 2020 South San Francisco / CA / USA - Merck & Co. logo at their headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational Stock Photo - Alamy](https://c8.alamy.com/comp/2DE98H1/sep-21-2020-south-san-francisco-ca-usa-merck-co-logo-at-their-headquarters-in-silicon-valley-merck-co-inc-is-an-american-multinational-2DE98H1.jpg)
Sep 21, 2020 South San Francisco / CA / USA - Merck & Co. logo at their headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational Stock Photo - Alamy
![Merck in Austin? Pharma firm considers “Innovation” location, Austin city incentives - News - The Austin Chronicle Merck in Austin? Pharma firm considers “Innovation” location, Austin city incentives - News - The Austin Chronicle](https://www.austinchronicle.com/binary/4914/MERCK-2.jpg)